Targeting DNA damage response pathways for the treatment of advanced lung cancer
Ended Project Grant Awarded Last action
- Award ID
- R41ES025596
- Recipient
-
Cumberland Pharmaceuticals, Inc. UEI M2ZXA6LYJ3S5
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $224,910
Award facts
- Assistance listing
- 93.113 Environmental Health
- Completion date
- Originally
- Place of performance
- Nashville, TN 37203, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,910 |
Quick answers
Who received award R41ES025596?
R41ES025596 was awarded to Cumberland Pharmaceuticals, Inc. by National Institutes of Health (Department of Health and Human Services) on September 22, 2014.
How much is award R41ES025596 worth?
$224,910 has been obligated on R41ES025596.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award